(Q33749026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515527%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

review article

1 reference

title

The use of intermittent itraconazole therapy for superficial mycotic infections: a review and update on the 'one week' approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515527%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515527%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

J Q Del Rosso

0 references

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515527%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Dermatology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515527%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

38 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515527%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

28-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515527%20AND%20SRC:MED&resulttype=core&format=json

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Antifungal agents: an overview. Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole in Antifungal Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole for the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Oral treatment options for onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: an open multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Cutaneous polyarteritis nodosa: a report of a case associated with melioidosis (Burkholderia pseudomallei).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole Compared with Griseofulvin in the Treatment of Tinea corporis/cruris and Tinea pedis/manus: An Interpretation of the Clinical Results of all Completed Double-Blind Studies with Respect to the Pharmacokinetic Profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole in the treatment of superficial mycoses--a double-blind study vs. placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Current management of onychomycosis. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole in onychomycosis: intermittent dose schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

New therapies for onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Small-dose itraconazole pulse therapy in the treatment of onychomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Candida onychomycosis--an evaluation of the role of Candida species in nail disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Onychomycosis in children: prevalence and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole oral solution for the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

The effect of toenail onychomycosis on patient quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Treatment of tinea capitis with itraconazole capsule pulse therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole oral solution for the treatment of tinea capitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Partial surgical avulsion of the nail in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Adverse drug reactions to systemic antifungals. Prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Cytochrome P-450 3A: interactions with dermatologic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Safety of itraconazole in diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Fungal infections in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole pulse therapy is effective in the treatment of Majocchi's granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole for the treatment of tinea pedis: A dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Oral antifungal agents for onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Onychomycosis in children: prevalence and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

Itraconazole pulse therapy for tinea capitis: a novel treatment schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00011.X

10.1046/J.1365-4362.1999.00011.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515527%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference